Delivery Order SPE2DB24D1201-SPE2DB25FJDYK
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,385.52 to AmerisourceBergen Drug Corp for 30 tablets of Orgovyx 120 mg on August 19, 2025, with an ultimate completion date of September 10, 2025. This competitively awarded, firm fixed-price contract involves no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Orgovyx is a prescription medication used in the treatment of prostate cancer, reflecting the...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $1,385.52 firm fixed price delivery order for 30 tablets of Orgovyx 120 mg on August 4, 2025, with an ultimate completion date of August 25, 2025. This non-set-aside competitive award is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The pharmaceutical product will be performed at...
- The Defense Logistics Agency awarded a delivery order valued at $2,771.04 to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Orgovyx 120 mg tablets (30-unit packages). This is a firm fixed-price, non-set-aside contract with a completion date of August 14, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. Orgovyx is a prescription medication used in the treatment of prostate cancer, representing the type of specialized pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $24,939.36 to AmerisourceBergen Drug Corp for 30-unit supplies of Orgovyx 120 mg tablets, with an ultimate completion date of August 26, 2025. This competitively awarded, firm fixed-price contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), which carries a potential value of $999,999,999.00 through December 2026. The place of performance is located...
- The Defense Logistics Agency awarded a firm fixed price delivery order to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of Orgovyx 120 mg tablets (30-count units) with a contract ceiling value of $1,385.52. This non-set-aside competitive award is set for completion by September 10, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions...
- The Defense Logistics Agency awarded a delivery order valued at $16,626.24 to AmerisourceBergen Drug Corp for the supply of Orgovyx 120 mg tablets (30-count units) on July 21, 2025, with an ultimate completion date of August 11, 2025. This is a firm fixed price delivery order with no set-aside designation, indicating competitive award. The product will be delivered to AmerisourceBergen's location in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger Indefinite...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp Corporate Office Division. The $7,979.34 firm fixed-price contract is for the supply of 120 mg Orgovyx tablets. Orgovyx is a prescription medication used to treat advanced prostate cancer. The contract has an ultimate completion date of August 28, 2024. Amerisourcebergen is a major pharmaceutical distributor that has been awarded numerous federal contracts to provide...
- The Defense Logistics Agency awarded a delivery order valued at $2,771.04 to AmerisourceBergen Drug Corp for 30 tablets of Orgovyx 120 mg, a prescription medication used in the treatment of prostate cancer. The contract is a firm fixed price delivery order with an ultimate completion date of August 8, 2025, and was competitively awarded without set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform fulfillment from its corporate office...
- This delivery order, awarded August 11, 2025, by the Defense Logistics Agency's Medical Supply Chain to AmerisourceBergen Drug Corp, provides 120 mg tablets of Orgovyx in quantities of 30 tablets. The contract is valued at $1,385.52 with a firm fixed price structure and is scheduled for completion by September 2, 2025. This is a competitively awarded order with no set-aside designation, reflecting AmerisourceBergen's capability to compete in the open federal pharmaceutical procurement...
- The Defense Logistics Agency awarded a $4,156.56 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Orgovyx 120 mg tablets (30-count units) on August 4, 2025, with an ultimate completion date of August 25, 2025. This delivery order represents a competitive award with no set-aside designation and is being performed at the vendor's corporate office location in Conshohocken, Pennsylvania. Orgovyx is a pharmaceutical product used in hormone therapy, consistent with...
- SPE2DB24D1201Indefinite Delivery Contract
- SPE2DB24D1201-SPE2DB25FJDYKDelivery Order
The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a firm fixed price delivery order valued at $1,385.52 for 30 tablets of Orgovyx 120 mg on August 19, 2025, with completion expected by September 10, 2025. The contract, which carries no set-aside designation, will be performed at the company's corporate office in Conshohocken, Pennsylvania. Orgovyx is a prescription medication used in the treatment of prostate cancer, representing a specialized pharmaceutical commodity within the federal medical supply chain. This delivery order is issued under AmerisourceBergen Drug Corp's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at approximately $1 billion through December 2026. As a leading pharmaceutical distributor and healthcare solutions provider, AmerisourceBergen Drug Corp serves as a critical vendor for military and veteran healthcare systems, supplying an extensive portfolio of medications, vaccines, and medical devices across multiple therapeutic domains. The company's federal contract awards demonstrate consistent capability in meeting competitive procurement requirements and supporting the Defense Health Agency and other government healthcare systems through flexible contract vehicles designed to address global pharmaceutical support needs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.4k | 8/19/25 |